| Contraction of T cell richness in lung cancer brain metastases AS Mansfield, H Ren, S Sutor, V Sarangi, A Nair, J Davila, LR Elsbernd, ... Scientific reports 8 (1), 1-9, 2018 | 76 | 2018 |
| SoftSearch: integration of multiple sequence features to identify breakpoints of structural variations SN Hart, V Sarangi, R Moore, S Baheti, JD Bhavsar, FJ Couch, ... PloS one 8 (12), e83356, 2013 | 53 | 2013 |
| Proteomic detection of immunoglobulin light chain variable region peptides from amyloidosis patient biopsies S Dasari, JD Theis, JA Vrana, OM Meureta, PS Quint, P Muppa, ... Journal of proteome research 14 (4), 1957-1967, 2015 | 49 | 2015 |
| PatternCNV: a versatile tool for detecting copy number changes from exome sequencing data C Wang, JM Evans, AV Bhagwate, N Prodduturi, V Sarangi, M Middha, ... Bioinformatics 30 (18), 2678-2680, 2014 | 49 | 2014 |
| Novel deleterious dihydropyrimidine dehydrogenase variants may contribute to 5‐fluorouracil sensitivity in an East African population T Elraiyah, CR Jerde, S Shrestha, R Wu, Q Nie, NH Giama, V Sarangi, ... Clinical Pharmacology & Therapeutics 101 (3), 382-390, 2017 | 40 | 2017 |
| Amplification of 9p24. 1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma Y Wang, K Wenzl, MK Manske, YW Asmann, V Sarangi, PT Greipp, ... Blood cancer journal 9 (9), 73, 2019 | 37 | 2019 |
| Early developmental asymmetries in cell lineage trees in living individuals L Fasching, Y Jang, S Tomasi, J Schreiner, L Tomasini, MV Brady, T Bae, ... Science 371 (6535), 1245-1248, 2021 | 32 | 2021 |
| CYP2C9 and CYP2C19: Deep Mutational Scanning and Functional Characterization of Genomic Missense Variants L Zhang, V Sarangi, I Moon, J Yu, D Liu, S Devarajan, JM Reid, KR Kalari, ... Clinical and translational science 13 (4), 727-742, 2020 | 32 | 2020 |
| Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma K Wenzl, MK Manske, V Sarangi, YW Asmann, PT Greipp, HR Schoon, ... Blood cancer journal 8 (10), 97, 2018 | 28 | 2018 |
| HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer Y Ren, Y Cherukuri, DP Wickland, V Sarangi, S Tian, JM Carter, ... Oncoimmunology 9 (1), 1744947, 2020 | 25 | 2020 |
| Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL KT Hartert, K Wenzl, JE Krull, M Manske, V Sarangi, Y Asmann, ... Leukemia 35 (2), 522-533, 2021 | 21 | 2021 |
| Inherited variants at 3q13. 33 and 3p24. 1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways G Kleinstern, H Yan, MAT Hildebrandt, J Vijai, SI Berndt, H Ghesquières, ... Human molecular genetics 29 (1), 70-79, 2020 | 21 | 2020 |
| Amplification-free long-read sequencing of TCF4 expanded trinucleotide repeats in Fuchs Endothelial Corneal Dystrophy ED Wieben, RA Aleff, S Basu, V Sarangi, B Bowman, IJ McLaughlin, ... PLoS One 14 (7), e0219446, 2019 | 16 | 2019 |
| SLCO1B1: application and limitations of deep mutational scanning for genomic missense variant function L Zhang, V Sarangi, MF Ho, I Moon, KR Kalari, L Wang, ... Drug Metabolism and Disposition 49 (5), 395-404, 2021 | 15 | 2021 |
| Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients JE Krull, K Wenzl, KT Hartert, MK Manske, V Sarangi, MJ Maurer, ... Blood cancer journal 10 (11), 117, 2020 | 14 | 2020 |
| Identification of missing variants by combining multiple analytic pipelines Y Ren, JS Reddy, C Pottier, V Sarangi, S Tian, JP Sinnwell, ... BMC bioinformatics 19, 1-12, 2018 | 12 | 2018 |
| Genetic diversity of newly diagnosed follicular lymphoma YW Asmann, MJ Maurer, C Wang, V Sarangi, SM Ansell, AL Feldman, ... Blood cancer journal 4 (10), e256-e256, 2014 | 10 | 2014 |
| Comprehensive genomic profiling of a rare thyroid follicular dendritic cell sarcoma JI Davila, JS Starr, S Attia, C Wang, RA Knudson, BM Necela, V Sarangi, ... Rare Tumors 9 (2), 50-53, 2017 | 8 | 2017 |
| Frequent POLE-driven hypermutation in ovarian endometrioid cancer revealed by mutational signatures in RNA sequencing JI Davila, P Chanana, V Sarangi, ZC Fogarty, SJ Weroha, R Guo, ... BMC medical genomics 14 (1), 1-6, 2021 | 5 | 2021 |
| Fine-mapping of the non-coding variation driving the Caucasian LRRK2 GWAS signal in Parkinson's disease MG Heckman, C Labbé, AL Kolicheski, AI Soto-Beasley, RL Walton, ... Parkinsonism & related disorders 83, 22-30, 2021 | 5 | 2021 |
